BiotechTube
Home/Gero/Vadim Gladyshev, PhD
VG

Vadim Gladyshev, PhD

Scientific Advisor

Gero

Therapeutic Areas

AgingFibrosisNeurodegeneration

Gero Pipeline

DrugIndicationPhase
ProtoBind‑Diff Antibody CandidatesSystemic Aging / ResiliencePreclinical
Fibrosis Target ProgramFibrotic DiseasesPreclinical
Chugai Co‑Development AntibodyAge‑Related Immune DysfunctionPreclinical

Leadership Team at Gero

PF
Peter Fedichev, PhD
CEO, Co‑Founder
MK
Maxim Kholin
Chief Corporate Development Officer, Co‑Founder
AS
Aleksandr Sviridov
Chief Operating Officer
BK
Brian Kennedy, PhD
Independent Director, Board Member
YM
Yuri Melnichek
Board Member
View full Gero profile